[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359580-105":59,"doc-detail-359580-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","factors-influencing-pharmacokinetics-of-5-fluorouracil-in-cancer-patients-a-systematic-review-of-population-pharmacokinetic-models","Factors influencing pharmacokinetics of 5-fluorouracil in cancer patients - a systematic review of population pharmacokinetic models","","5-Fluorouracil (5-FU) is a traditional chemotherapeutic used across multiple cancers, yet its population pharmacokinetics (PopPK) vary widely due to patient and disease covariates. This systematic review summarizes PopPK models for intravenous and prodrug formulations and identifies covariates affecting key parameters such as clearance and volume of distribution. Searches through December 2025 screened 186 records, yielding 21 suitable studies, most using one-compartment models. SMI, body weight, sex, and BSA emerged as primary covariates, with sex influencing clearance and ALP showing a negative effect, highlighting interindividual variability.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/factors-influencing-pharmacokinetics-of-5-fluorouracil-in-cancer-patients-a-systematic-review-of-population-pharmacokinetic-models/359580/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/factors-influencing-pharmacokinetics-of-5-fluorouracil-in-cancer-patients-a-systematic-review-of-population-pharmacokinetic-models/359580.png","ImageObject",300,407,{"name":92,"@type":93},"Sophia Brooks","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What covariates most strongly influence 5-FU pharmacokinetics in cancer patients?","Question",{"text":113,"@type":114},"Skeletal muscle index (SMI), body weight, sex, and body surface area (BSA) were reported as the primary covariates affecting 5-FU pharmacokinetics.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does sex affect 5-FU clearance according to the review?",{"text":118,"@type":114},"Sex was identified as an important determinant of clearance, with males showing higher clearance than females.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is individualized dosing emphasized for 5-FU?",{"text":122,"@type":114},"Substantial interindividual variability across studies contributes to heterogeneity in covariate effects, supporting individualized dosing approaches and consideration of key covariates.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},359580,1790241558,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","European Journal of Clinical Pharmacology (2026) 82:126  \n[https://doi.org/10.1007/s00228-026-04043-5](https://doi.org/10.1007/s00228-026-04043-5)  \nREVIEW  \nFactors influencing pharmacokinetics of 5-fluorouracil in cancer patients: a systematic review of population pharmacokinetic models  \nTeshini Suthahar1· Jayashree Veerabhadrappa1 · Renuka Munshi2 · Elstin Anbu Raj1,3 · Vikram Gota4 · Vijay Ivaturi5 · Surulivelrajan Mallayasamy1  \nReceived: 14 October 2025 / Accepted: 28 March 2026 / Published online: 15 April 2026 © The Author(s) 2026  \nAbstract  \nPurpose 5-Fluorouracil (5-FU) is a traditional chemotherapeutic agent used in the treatment of multiple cancers. This systematic review aimed to summarize the population pharmacokinetic (PopPK) models for both intravenous and prodrug formulations in cancer patients and to understand the different covariates that affect the pharmacokinetics of 5-FU. Methods the search included studies published from inception to December 2025 in the English language. The non-linear mixed effects model with parametric approach for 5-FU in cancer patients was set as the inclusion criteria. A total of 186 articles were screened for their titles and abstracts from Scopus, PubMed and EMBASE. Out of which 156 were excluded. Out of the 36 articles reviewed, 21 were found suitable for the review. Most of the studies reported a one-compartmental model. Several covariates, including body surface area (BSA), body weight, cancer type, age, gender, UH2/U ratio, serum albumin, creatinine clearance, alkaline phosphatase, total bilirubin, and skeletal muscle index (SMI), influence the pharmacokinetic parameters, including clearance and volume of distribution. Results skeletal muscle index (SMI), body weight, sex, and BSA were the primary covariates influencing the pharmacokinetics of 5-FU. Among the covariates consistently reported as significant, sex was an important determinant of clearance, with males exhibiting higher clearance than females. Increases in body weight and skeletal muscle index were associated with increased clearance, while volume of distribution decreased with lower body surface area. Alkaline phosphatase was reported to have a negative effect on clearance. The substantial interindividual variability observed across studies likely contributes to heterogeneity in reported covariate effects and underscores the need for individualized dosing approaches for 5-FU. Conclusion body weight and sex reported to show clinical significance. This necessitates the need for consideration of these covariatesin dosing adjustment. This review summarizes covariates influencing the pharmacokinetics of 5-FU, and reports those identified as significant based on forest plot analysis. This study helps the researchers to perform predictive performance of the reported PopPK models, supporting future model-informed precision dosing strategies for 5-FU-based therapies.  \nKeywords Population Pharmacokinetics · 5-Fluorouracil · Non-linear mixed effects model · Pharmacokinetics · Systematic review  \nAbbreviations  \n5-FU 5-Fluorouracil  \nALP Alkaline phosphatase  \nALT Alanine transaminase  \nAST Aspartate transaminase  \nBd Direct bilirubin  \nBSA Body Surface Area  \nBt Total bilirubin  \nCDHP 5-chloro-2,4-dihydroxypyridine  \nExtended author information available on the last page of the article  \nCI  \nCL  \nCVI  \nDPD  \nDPYD  \nFO  \nFOCE-I  \ngGT  \nConfidence interval  \nClearance  \nContinuous venous infusion Dihydropyrimidine dehydrogenase  \nDihydropyrimidine dehydrogenase gene First order estimation method  \nFirst order conditional estimation method with interaction  \ng-glutamyl transpeptidase  \nGoF Goodness offit  \nIIV Interindividual variability  \nLDH Lactate dehydrogenase  \nPBMC-DPD Peripheral mononuclear cell dihydropyrimidine dehydrogenase  \nPK Pharmacokinetics  \nPopPK Population pharmacokinetics  \nPRISMA The Preferred Reporting Items for Systematic Reviews and Meta analyses  \nQ Intercompartmental clearance  \nS-1 Tegafur/gime","cbCaiaWdTfYCpqdM","https://ap.wps.com/l/cbCaiaWdTfYCpqdM","pdf",1965122,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What covariates most strongly influence 5-FU pharmacokinetics in cancer patients?\",\"answer\":\"Skeletal muscle index (SMI), body weight, sex, and body surface area (BSA) were reported as the primary covariates affecting 5-FU pharmacokinetics.\"},{\"question\":\"How does sex affect 5-FU clearance according to the review?\",\"answer\":\"Sex was identified as an important determinant of clearance, with males showing higher clearance than females.\"},{\"question\":\"Why is individualized dosing emphasized for 5-FU?\",\"answer\":\"Substantial interindividual variability across studies contributes to heterogeneity in covariate effects, supporting individualized dosing approaches and consideration of key covariates.\"}]","Factors influencing pharmacokinetics of 5-fluorouracil in cancer patients - a systematic review of population pharmacokinetic models | PDF",1790137213,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9c28f91b6cf4f3956775df624df23bd.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/145f838177e614256c0e63118769e8a4.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/337462a7969427c45e5ea990038506c3.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b05b08fc9697c1bf180e7ac34bfa1ee.webp",980,1301]